Wei‐Ming Li

6.9k citations
265 papers · 4.9k indexed · 1 hit paper · h-index 37
Topics
Bladder and Urothelial Cancer Treatments (59 papers)Urinary and Genital Oncology Studies (28 papers)Ferroptosis and cancer prognosis (21 papers)
Journals
CirculationSHILAP Revista de lepidopterologíaPLoS ONE
Partner nations
TaiwanChinaUnited States

In The Last Decade

Wei‐Ming Li

254 papers receiving 4.8k citations

Hit Papers

High Doses of Bone Morphogenetic Protein 2 Induce Structu...20112026201620212011100200300400

Peers

Wei‐Ming Li
Comparison fields: 5 of 162
  • Molecular Biology 1.6k
  • Surgery 1.1k
  • Pulmonary and Respiratory Medicine 699
  • Cancer Research 659
  • Oncology 594
Replace Chang Yin Liang with:
Chang Yin Liang China
Guohui Liu China
Stuart Bunting United States
Linda M. McManus United States
Wen‐Jeng Wu Taiwan
Melpo Christofidou‐Solomidou United States
Philippe Gillery France
Lianming Liao China
Omaida C. Velázquez United States
Joaquín J. Jiménez United States
Wei‐Ming Li relative to Chang Yin Liang China Chang Yin Liang's profile →
Citations per field
00.5×1.7×
Chang Yin Liang · 1×
Citations per year

Countries citing papers authored by Wei‐Ming Li

Since Specialization
Citations

This map shows the geographic impact of Wei‐Ming Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Ming Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Ming Li more than expected).

Fields of papers citing papers by Wei‐Ming Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei‐Ming Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Ming Li. The network helps show where Wei‐Ming Li may publish in the future.

Co-authorship network of co-authors of Wei‐Ming Li

This figure shows the co-authorship network connecting the top 25 collaborators of Wei‐Ming Li. A scholar is included among the top collaborators of Wei‐Ming Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei‐Ming Li. Wei‐Ming Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 1
4 2
5 6
6 16
7 6
8 2
9 14
10 9
11 22
12 5
13 13
14 26
15 4
16 36
17 32
18 28
19
Comparative study on transradial versus transfemoral approach for primary percutaneous coronary intervention in Chinese patients with acute myocardial infarction.
53
20 11

About Wei‐Ming Li

Wei‐Ming Li is a scholar working on Cancer Research, Surgery and Urology, having authored 265 papers that have together received 4.9k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (59 papers), Urinary and Genital Oncology Studies (28 papers) and Ferroptosis and cancer prognosis (21 papers). The work is most often cited by research in Urology (417 citations), Cancer Research (659 citations) and Endocrinology, Diabetes and Metabolism (414 citations). Wei‐Ming Li has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Wen‐Jeng Wu, Hung‐Lung Ke, Hsin‐Chih Yeh, Chun‐Nung Huang, Ching‐Chia Li, Chien‐Feng Li, Yawei Xu, San‐Yuan Chen, Ching‐Chia Li and Chia‐Chu Liu. Their work appears in journals such as Circulation, SHILAP Revista de lepidopterología and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026